{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T20:36:57Z","timestamp":1792442217525,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["OMRPG3E0041"],"award-info":[{"award-number":["OMRPG3E0041"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CLRPG2E0051"],"award-info":[{"award-number":["CLRPG2E0051"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPG1F0111"],"award-info":[{"award-number":["CMRPG1F0111"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006441","name":"Center for Outcomes Research and Evaluation, Yale School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006441","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.jid.2018.10.048","type":"journal-article","created":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T13:09:00Z","timestamp":1549372140000},"page":"1722-1731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Increased Type 2 Innate Lymphoid Cells in\u00a0Patients with Drug Reaction with Eosinophilia\u00a0and Systemic Symptoms Syndrome"],"prefix":"10.1016","volume":"139","author":[{"given":"Yi-Giien","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Hung","family":"Liou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuen-Iu","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsu-Man","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuang-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2018.10.048_bib1","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/exd.12887","article-title":"Do not be alarmed: understanding IL33-ST2 signalling in wound repair","volume":"25","author":"Ansell","year":"2016","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2018.10.048_bib2","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.clinthera.2016.02.021","article-title":"Potential therapeutic aspects of alarmin cytokine interleukin 33 or its inhibitors in various diseases","volume":"38","author":"Arshad","year":"2016","journal-title":"Clin Ther"},{"key":"10.1016\/j.jid.2018.10.048_bib3","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/exd.12027","article-title":"IL-33 is secreted by psoriatic keratinocytes and induces pro-inflammatory cytokines via keratinocyte and mast cell activation","volume":"21","author":"Balato","year":"2012","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jid.2018.10.048_bib4","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00403-016-1638-7","article-title":"Interleukin-33: increasing role in dermatological conditions","volume":"308","author":"Balato","year":"2016","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jid.2018.10.048_bib5","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","article-title":"The DRESS syndrome: a literature review","volume":"124","author":"Cacoub","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.jid.2018.10.048_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.coi.2014.09.004","article-title":"IL-33: an alarmin cytokine with crucial roles in innate\u00a0immunity, inflammation and allergy","volume":"31","author":"Cayrol","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jid.2018.10.048_bib7","article-title":"The function of HLA-B*13:01 involved in the pathomechanism of dapsone-induced severe cutaneous adverse reactions","author":"Chen","year":"2018","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2018.10.048_bib8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jaad.2012.08.009","article-title":"Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: a retrospective cohort study from Taiwan","volume":"68","author":"Chen","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jid.2018.10.048_bib9","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.jaci.2008.04.005","article-title":"A\u00a0novel IL-1 family cytokine, IL-33, potently activates human eosinophils","volume":"121","author":"Cherry","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2018.10.048_bib10","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.immuni.2008.04.020","article-title":"Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity","volume":"28","author":"Chessman","year":"2008","journal-title":"Immunity"},{"issue":"6982","key":"10.1016\/j.jid.2018.10.048_bib11","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/428486a","article-title":"Medical genetics: a marker for Stevens-Johnson syndrome","volume":"428","author":"Chung","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.jid.2018.10.048_bib12","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nm.1884","article-title":"Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"14","author":"Chung","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.jid.2018.10.048_bib13","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/1346-8138.13430","article-title":"Severe cutaneous adverse drug reactions","volume":"43","author":"Chung","year":"2016","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.jid.2018.10.048_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12876-016-0520-6","article-title":"Soluble ST2 is a sensitive clinical marker of ulcerative colitis evolution","volume":"16","author":"Diaz-Jimenez","year":"2016","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jid.2018.10.048_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.clinre.2014.10.012","article-title":"Overexpression of serum sST2 is associated with poor prognosis in acute-on-chronic hepatitis B liver failure","volume":"39","author":"Gao","year":"2015","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jid.2018.10.048_bib16","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3389\/fimmu.2017.00475","article-title":"The ST2\/IL-33 axis in immune cells during inflammatory diseases","volume":"8","author":"Griesenauer","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jid.2018.10.048_bib17","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.coi.2016.05.004","article-title":"Interleukin-33, friend and foe in type-2 immune responses","volume":"42","author":"Hardman","year":"2016","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jid.2018.10.048_bib18","doi-asserted-by":"crossref","first-page":"26369","DOI":"10.1074\/jbc.M704916200","article-title":"Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation","volume":"282","author":"Hayakawa","year":"2007","journal-title":"J\u00a0Biol Chem"},{"issue":"9312","key":"10.1016\/j.jid.2018.10.048_bib19","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0140-6736(02)08158-8","article-title":"Genetic variations in HLA-B region and hypersensitivity reactions to abacavir","volume":"359","author":"Hetherington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2018.10.048_bib20","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3346\/jkms.2011.26.9.1132","article-title":"Measurement of interleukin-33 (IL-33) and IL-33 receptors (sST2 and ST2L) in patients with rheumatoid arthritis","volume":"26","author":"Hong","year":"2011","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.jid.2018.10.048_bib21","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12879-016-1543-x","article-title":"Relevance of serum interleukin-33 and ST2 levels and the natural course of chronic hepatitis B virus infection","volume":"16","author":"Huan","year":"2016","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jid.2018.10.048_bib22","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.0409500102","article-title":"HLA-B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol","volume":"102","author":"Hung","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jid.2018.10.048_bib23","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/j.1365-2222.2011.03797.x","article-title":"The role of thymic stromal lymphopoietin in the immunopathogenesis of atopic dermatitis","volume":"41","author":"Jariwala","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jid.2018.10.048_bib24","doi-asserted-by":"crossref","first-page":"264","DOI":"10.3899\/jrheum.140234","article-title":"The interleukin 33\/ST2 axis in patients with primary Sj\u00f6gren syndrome: expression in serum and salivary glands, and the clinical association","volume":"42","author":"Jung","year":"2015","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.jid.2018.10.048_bib25","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/bjd.12501","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study","volume":"169","author":"Kardaun","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2018.10.048_bib26","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2018.10.048_bib27","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.3346\/jkms.2013.28.8.1145","article-title":"Serum level of interleukin-33 and soluble ST2 and their association with disease activity in patients with Beh\u00e7et's disease","volume":"28","author":"Kim","year":"2013","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.jid.2018.10.048_bib28","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.jaci.2011.08.013","article-title":"Shared and\u00a0restricted T-cell receptor use is crucial for carbamazepine-induced\u00a0Stevens-Johnson syndrome","volume":"128","author":"Ko","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2018.10.048_bib29","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fmed.2017.00136","article-title":"Regulation of eosinophil and group 2 innate lymphoid cell trafficking in asthma","volume":"4","author":"Larose","year":"2017","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jid.2018.10.048_bib30","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nri.2016.95","article-title":"Interleukin-33 in health and disease","volume":"16","author":"Liew","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jid.2018.10.048_bib31","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.ajpath.2017.02.010","article-title":"Local group 2 innate lymphoid cells promote corneal regeneration after epithelial abrasion","volume":"187","author":"Liu","year":"2017","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jid.2018.10.048_bib32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.29262\/ram.v61i1.16","article-title":"Prevalence of DRESS syndrome","volume":"61","author":"Lopez-Rocha","year":"2014","journal-title":"Rev Alerg Mex"},{"key":"10.1016\/j.jid.2018.10.048_bib33","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1189\/jlb.3RI1214-595R","article-title":"New dog and new tricks: evolving roles for IL-33 in type 2 immunity","volume":"97","author":"Lott","year":"2015","journal-title":"J\u00a0Leukoc Biol"},{"issue":"9308","key":"10.1016\/j.jid.2018.10.048_bib34","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(02)07873-X","article-title":"Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir","volume":"359","author":"Mallal","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2018.10.048_bib35","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/cvr\/cvq104","article-title":"Primary sources and immunological prerequisites for sST2 secretion in humans","volume":"87","author":"Mildner","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jid.2018.10.048_bib36","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/rheumatology\/kep402","article-title":"Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus","volume":"49","author":"Mok","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jid.2018.10.048_bib37","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.immuni.2015.06.006","article-title":"Interleukin-33 in tissue homeostasis, injury, and inflammation","volume":"42","author":"Molofsky","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.jid.2018.10.048_bib38","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A\u00a0method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"issue":"7 suppl","key":"10.1016\/j.jid.2018.10.048_bib39","doi-asserted-by":"crossref","first-page":"3B","DOI":"10.1016\/j.amjcard.2015.01.034","article-title":"The biology of ST2: the International ST2 Consensus Panel","volume":"115","author":"Pascual-Figal","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jid.2018.10.048_bib40","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.4049\/jimmunol.169.8.4604","article-title":"The relationship between allergen-induced tissue eosinophilia and markers of repair and remodeling in human atopic skin","volume":"169","author":"Phipps","year":"2002","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jid.2018.10.048_bib41","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ijcard.2014.11.097","article-title":"Serial soluble ST2 for the monitoring of pharmacologically optimised chronic stable heart failure","volume":"178","author":"Piper","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jid.2018.10.048_bib42","doi-asserted-by":"crossref","first-page":"2939","DOI":"10.1084\/jem.20130351","article-title":"A\u00a0role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis","volume":"210","author":"Salimi","year":"2013","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jid.2018.10.048_bib43","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/jid.2011.446","article-title":"IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors","volume":"132","author":"Savinko","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2018.10.048_bib44","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1002\/eji.201545780","article-title":"Interleukin 33: an innate alarm for adaptive responses beyond Th2 immunity-emerging roles in obesity, intestinal inflammation, and cancer","volume":"46","author":"Schwartz","year":"2016","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jid.2018.10.048_bib45","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/jid.2012.510","article-title":"Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis","volume":"133","author":"Sekula","year":"2013","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2018.10.048_bib46","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/ACI.0000000000000180","article-title":"Monitoring the acute response in severe hypersensitivity reactions to drugs","volume":"15","author":"Shiohara","year":"2015","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2018.10.048_bib47","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1111\/jdv.13212","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): clinicopathological study of 45 cases","volume":"29","author":"Skowron","year":"2015","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jid.2018.10.048_bib48","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1136\/bjo.2007.133967","article-title":"Use of multiplex PCR and real-time PCR to detect human herpes virus genome in ocular fluids of patients with uveitis","volume":"92","author":"Sugita","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jid.2018.10.048_bib49","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1038\/jid.2015.85","article-title":"Epidermal Expression and regulation of interleukin-33 during homeostasis and inflammation: strong species differences","volume":"135","author":"Sundnes","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2018.10.048_bib50","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1038\/jid.2014.146","article-title":"Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients","volume":"134","author":"Teunissen","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2018.10.048_bib51","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/cyto.b.21614","article-title":"Human innate lymphoid cells (ILCs): toward a uniform immune-phenotyping","volume":"94","author":"Trabanelli","year":"2018","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/j.jid.2018.10.048_bib52","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jcmgh.2017.01.005","article-title":"Thymic stromal lymphopoietin: to cut a long story short","volume":"3","author":"Tsilingiri","year":"2017","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jid.2018.10.048_bib53","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1684\/ejd.2012.1706","article-title":"The levels of soluble ST2 in sera and bullous fluid from patients with bullous pemphigoid","volume":"22","author":"Wakatabi","year":"2012","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jid.2018.10.048_bib54","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jaci.2013.04.036","article-title":"A\u00a0new nucleic acid-based agent inhibits cytotoxic T lymphocyte-mediated immune disorders","volume":"132","author":"Wang","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2018.10.048_bib55","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.jaci.2011.12.990","article-title":"Direct interaction between HLA-B and carbamazepine activates T cells in patients with\u00a0Stevens-Johnson syndrome","volume":"129","author":"Wei","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2018.10.048_bib56","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.molimm.2013.05.225","article-title":"IL-33 accelerates cutaneous wound healing involved in upregulation of alternatively activated macrophages","volume":"56","author":"Yin","year":"2013","journal-title":"Mol Immunol"},{"key":"10.1016\/j.jid.2018.10.048_bib57","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1056\/NEJMoa1213096","article-title":"HLA-B*13:01 and the dapsone hypersensitivity syndrome","volume":"369","author":"Zhang","year":"2013","journal-title":"N\u00a0Engl J Med"},{"issue":"308","key":"10.1016\/j.jid.2018.10.048_bib58","doi-asserted-by":"crossref","first-page":"308ra160","DOI":"10.1126\/scitranslmed.aab0166","article-title":"ST2 blockade reduces sST2-producing T cells while maintaining protective mST2-expressing T cells during graft-versus-host disease","volume":"7","author":"Zhang","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jid.2018.10.048_bib59","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.clim.2017.09.008","article-title":"Increased innate type 2 immune response in house dust mite-allergic patients with allergic rhinitis","volume":"183","author":"Zhong","year":"2017","journal-title":"Clin Immunol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X19301009?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X19301009?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T21:43:55Z","timestamp":1762206235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X19301009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":59,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0022202X19301009"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2018.10.048","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased Type 2 Innate Lymphoid Cells in\u00a0Patients with Drug Reaction with Eosinophilia\u00a0and Systemic Symptoms Syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2018.10.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}